Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Calea is a leading provider of home healthcare services, specializing in home infusion therapy and clinical nutrition for patients with complex medical needs. Operating as a subsidiary of Fresenius Kabi, the company provides a vertically integrated service model that includes aseptic compounding, specialized pharmacy dispensing, and home delivery of medications. Their clinical focus primarily targets patients suffering from intestinal failure, chronic kidney disease, and various conditions requiring long-term intravenous support. Calea also provides dedicated nursing services to ensure the safe administration of therapies such as parenteral nutrition and chemotherapy in a domestic setting. By transitioning care from hospitals to the home, the company plays a critical role in improving patient autonomy and reducing healthcare system burdens.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Calea.